Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Cory

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Advances in Enzyme Regulation|January 1, 1983
Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in cultureA Sato, G L Carter, P E Bacon, et al.
Cancer Research|November 1, 1982
Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in cultureA Sato, G L Carter, P E Bacon, et al.
Biochemical Pharmacology|February 15, 1984
Effect of combinations of deoxyguanosine and 8-aminoguanosine with 2,3-dihydro-1H-imidazo[1,2-b]pyrazole on L1210 cell growth in cultureA Sato, P E Bacon, S W Schneller, et al.
Oncology Research|January 1, 1996
Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazoneA H Cory, A Sato, D P Thompson, et al.
Cancer Research|November 15, 1988
Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductaseM T Williams, L Simonet, A H Cory, et al.
Advances in Enzyme Regulation|January 1, 1997
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosineJ G Cory, T O Nelson, L Somerville, et al.
The Journal of Biological Chemistry|January 5, 1993
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activityA H Cory, I A Shibley, J M Chalovich, et al.
Anticancer Research|April 13, 2001
Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cellsJ G Hall, A H Cory, D H Hickerson, et al.
Oncology Research|January 1, 1993
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cellsA H Cory, L W Hertel, J S Kroin, et al.
Oncology Research|January 1, 1992
5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cellsJ G Cory, D L Downes, C Y Ng, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Advances in Enzyme Regulation|January 1, 1983
Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in cultureA Sato, G L Carter, P E Bacon, et al.
Cancer Research|November 1, 1982
Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in cultureA Sato, G L Carter, P E Bacon, et al.
Biochemical Pharmacology|February 15, 1984
Effect of combinations of deoxyguanosine and 8-aminoguanosine with 2,3-dihydro-1H-imidazo[1,2-b]pyrazole on L1210 cell growth in cultureA Sato, P E Bacon, S W Schneller, et al.
Oncology Research|January 1, 1996
Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazoneA H Cory, A Sato, D P Thompson, et al.
Cancer Research|November 15, 1988
Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductaseM T Williams, L Simonet, A H Cory, et al.
Advances in Enzyme Regulation|January 1, 1997
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosineJ G Cory, T O Nelson, L Somerville, et al.
The Journal of Biological Chemistry|January 5, 1993
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activityA H Cory, I A Shibley, J M Chalovich, et al.
Anticancer Research|April 13, 2001
Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cellsJ G Hall, A H Cory, D H Hickerson, et al.
Oncology Research|January 1, 1993
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cellsA H Cory, L W Hertel, J S Kroin, et al.
Oncology Research|January 1, 1992
5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cellsJ G Cory, D L Downes, C Y Ng, et al.
Pageof 12